SFSIG
ARRY

San Francisco Sentry Investment Group’s Array Biopharma Inc ARRY Stock Holding History

San Francisco Sentry Investment Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-574
Closed -$26K – 956
2019
Q2 		$26K Hold
574
– – 0.01% 453
2019
Q1 		$14K Hold
574
– – 0.01% 533
2018
Q4 		$8K Buy
574
+49
+9% +$743 ﹤0.01% 592
2018
Q3 		$8K Hold
525
– – ﹤0.01% 620
2018
Q2 		$9K Hold
525
– – ﹤0.01% 581
2018
Q1 		$9K Buy
+525
New +$8.41K ﹤0.01% 708

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

San Francisco Sentry Investment Group's ARRY Position: Q3 2019 in Review

San Francisco Sentry Investment Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 574 shares — an estimated $26K sold.

San Francisco Sentry Investment Group first reported a position in ARRY in Q1 2018 and held it in 6 quarters. The position peaked at $26K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • San Francisco Sentry Investment Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 574 Array Biopharma Inc shares in Q3 2019, an estimated $26K.
  • San Francisco Sentry Investment Group first reported a position in Array Biopharma Inc in Q1 2018 and held it in 6 quarters.
  • San Francisco Sentry Investment Group's Array Biopharma Inc position peaked at $26K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on San Francisco Sentry Investment Group's 13F filing for Q3 2019, filed 18 Oct 2019.